Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
16.83
-1.31 (-7.22%)
At close: Apr 1, 2025, 4:00 PM
19.17
+2.34 (13.88%)
After-hours: Apr 1, 2025, 4:25 PM EDT

Dianthus Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-84.97-43.56-28.48-13.11
Depreciation & Amortization
0.410.360.15-
Loss (Gain) From Sale of Investments
-6.17-1.42-0.61-
Stock-Based Compensation
12.892.91.520.06
Change in Accounts Receivable
0.180.750.07-1.01
Change in Accounts Payable
8.190.662.284.92
Change in Unearned Revenue
1.55-0.060.89-
Change in Other Net Operating Assets
-10.283.5-4.89-0.77
Operating Cash Flow
-78.18-36.86-29.07-9.9
Capital Expenditures
-0.11-0.11-0.14-0.03
Investment in Securities
-286.7120.36-59.68-
Investing Cash Flow
-286.8120.25-59.82-0.03
Short-Term Debt Issued
-0.38--
Total Debt Issued
-0.38--
Short-Term Debt Repaid
--0.38--
Total Debt Repaid
--0.38--
Issuance of Common Stock
270.290.01--
Other Financing Activities
-14.67133.57-3.32-0.09
Financing Cash Flow
255.62133.5796.6814.91
Net Cash Flow
-109.37116.977.794.98
Free Cash Flow
-78.29-36.97-29.21-9.94
Free Cash Flow Margin
-1255.57%-1308.24%-455.18%-673.24%
Free Cash Flow Per Share
-2.35-7.17-33.41-2.48
Levered Free Cash Flow
-43.48-22.81-19.31-
Unlevered Free Cash Flow
-43.48-22.81-19.31-
Change in Net Working Capital
-6.99-4.152.27-
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q